TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25322173

Group type: EXPERIMENTAL
Intervention: Corneas from donors younger than 66 years
Number of subjects: 1090

Group type: COMPARATOR
Intervention: Corneas from donors 66 years or older
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Participants with a history of glaucoma before penetrating keratoplasty
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Participants aged 70 years or older
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: African American recipients
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Recipients with a history of smoking
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Lower endothelial cell density (ECD) at 6 months
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Higher corneal thickness (CT) at 6 months
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Lower ECD at 1 year
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Higher CT at 1 year
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Lower ECD at 5 years
Number of subjects: 1090

Group type: EXPERIMENTAL
Intervention: Higher CT at 5 years
Number of subjects: 1090
Study: 23358295

Group type: EXPERIMENTAL
Intervention: Nutrition and Physical Activity (NPA) intervention
Number of subjects: 673

Group type: COMPARATOR
Intervention: Cancer Education (CE)
Number of subjects: 673
Study: 21640042

Group type: EXPERIMENTAL
Intervention: Colchicine 0.5mg BID
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 19363703

Group type: EXPERIMENTAL
Intervention: Tetanus toxoid (TT)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Tetanus and reduced diphtheria (Td)
Number of subjects: 131
Study: 16848997

Group type: EXPERIMENTAL
Intervention: SBC (selective brain cooling) group
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: MSH (mild systemic hypothermia) group
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (normothermia) group
Number of subjects: 96
Study: 16048569

Group type: EXPERIMENTAL
Intervention: Large volume paracentesis (LVP) with intravenous albumin
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diuretics with intravenous albumin
Number of subjects: 42
Study: 11930101

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (1.2 mg/kg)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 10594421

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 20

Group type: COMPARATOR
Intervention: Desflurane
Number of subjects: 20
Study: 8597003

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 200 mg 4-hourly
Number of subjects: 191

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone 125 mg 12-hourly
Number of subjects: 191
Study: 2132290

Group type: EXPERIMENTAL
Intervention: morniflumate (700 mg tablet twice a day) + amoxicillin (1 g tablet twice a day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: feprazone (200 mg tablet twice a day) + amoxicillin (1 g tablet twice a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: amoxicillin (1 g tablet twice a day)
Number of subjects: 60
Study: 500516

Group type: COMPARATOR
Intervention: GENT alone at a dose of 1.5 mg/kg/8 hourly
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: GENT + CTIN at a dose of 2 g or 3 g 8 hourly by i.v. bolus
Number of subjects: 67
Study: 31703674

Group type: EXPERIMENTAL
Intervention: Burnout assessment using Maslach Burnout Inventory-Human Services Survey (MBI-HSS)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Emotional Exhaustion (EE)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Depersonalization (DP)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Personal Accomplishment (PA)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Dissatisfaction with practice lecturer
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Moderate social support
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Satisfaction with education
Number of subjects: 151
Study: 28086181

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 82

Group type: COMPARATOR
Intervention: Brief treatment
Number of subjects: 82
Study: 25431429

Group type: EXPERIMENTAL
Intervention: Social recovery cognitive-behavioural therapy (SRCBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 23595562

Group type: COMPARATOR
Intervention: Bazedoxifene (BZA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Raloxifene (RLX) 60 mg
Number of subjects: 0
Study: 21550357

Group type: EXPERIMENTAL
Intervention: Food anticipation (14 subjects)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Withholding anticipated food (14 subjects)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fasted controls (15 subjects)
Number of subjects: 29
Study: 19736154

Group type: EXPERIMENTAL
Intervention: Biolimus-eluting biodegradable polymer stents (BES)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Sirolimus-eluting permanent polymer stents (SES)
Number of subjects: 153
Study: 17845921

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg/day) for 4 weeks
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Telmisartan (40 mg/day) for 4 weeks
Number of subjects: 35
Study: 14743356

Group type: EXPERIMENTAL
Intervention: Dyskinesias
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: Younger subjects
Number of subjects: 301

Group type: COMPARATOR
Intervention: Motor fluctuations
Number of subjects: 301

Group type: COMPARATOR
Intervention: Treatment regimen
Number of subjects: 301
Study: 11770416

Group type: EXPERIMENTAL
Intervention: Community intervention for COPD and chronic cor-pulmonale
Number of subjects: 3739

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3739
Study: 9670269

Group type: EXPERIMENTAL
Intervention: Isolated hyperthermic liver perfusion (IHLP) with anticancer agents
Number of subjects: 10
Study: 7920751

Group type: EXPERIMENTAL
Intervention: Decapeptyl (D‐Trp6‐LHRH) depot 3.2 mg for 3‐6 months + conservative myomectomy
Number of subjects: 23

Group type: COMPARATOR
Intervention: Decapeptyl (D‐Trp6‐LHRH) depot 3.2 mg for 3‐6 months without myomectomy
Number of subjects: 23
Study: 2967712

Group type: EXPERIMENTAL
Intervention: Nitrous oxide-oxygen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxygen (control)
Number of subjects: 0
Study: 31525444

Group type: EXPERIMENTAL
Intervention: Topical application of concentrated water-in-oil emulsions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical application of concentrated water-in-oil emulsions with isopropyl myristate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical application of concentrated water-in-oil emulsions with liquid paraffin
Number of subjects: 0
Study: 29098783

Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS), 20 g/day
Number of subjects: 869

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients (MMN)
Number of subjects: 869

Group type: COMPARATOR
Intervention: Control iron/folic acid (IFA) tablet
Number of subjects: 869

Group type: COMPARATOR
Intervention: Placebo (for IFA control group post-delivery)
Number of subjects: 869
Study: 26976423

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus Irinotecan (BEV+IRI)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Temozolomide (TMZ)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Quality of life (QOL) measures (QLQ-C30 and QLQ-BN20)
Number of subjects: 182
Study: 24274259

Group type: EXPERIMENTAL
Intervention: 4 g of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) daily for 3 months
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 21954883

Group type: EXPERIMENTAL
Intervention: Gelsemium 15CH
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gelsemium 5CH
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Gelsemium 5CH and 15CH
Number of subjects: 180
Study: 20209421

Group type: EXPERIMENTAL
Intervention: Upper body physical training (UBT) for 12 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study: 17934422

Group type: EXPERIMENTAL
Intervention: Guidelines for management of patients on oral anticoagulants
Number of subjects: 0
Study: 16278591

Group type: EXPERIMENTAL
Intervention: Synthetic human atrial natriuretic peptide infusion (Group H: n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional diuretics (furosemide and potassium canrenoate) (Group C: n=18)
Number of subjects: 37
Study: 12003988

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 45

Group type: COMPARATOR
Intervention: Doxycycline/Ciprofloxacin
Number of subjects: 45
Study: 10549465

Group type: EXPERIMENTAL
Intervention: Prochlorperazine buccal 6 mg
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 7768761

Group type: EXPERIMENTAL
Intervention: Meropenem, 500 mg q 8 h
Number of subjects: 249

Group type: COMPARATOR
Intervention: Imipenem/cilastatin, 500 mg/500 mg q 8 h
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 249

Group type: COMPARATOR
Intervention: Imipenem/cilastatin
Number of subjects: 249
Study: 2348155

Group type: EXPERIMENTAL
Intervention: Anonymous questionnaires
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Numbered questionnaires
Number of subjects: 1800
Study: 378561

Group type: EXPERIMENTAL
Intervention: Undecylenic acid ointment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tolnaftate cream
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Undecylenic acid ointment and Tolnaftate cream
Number of subjects: 90
Study: 31687953

Group type: EXPERIMENTAL
Intervention: Antiseptic solution 'Decasan', probiotic 'BioGaia ProDentis', immune modulator 'Imupret'
Number of subjects: 0

Group type: COMPARATOR
Intervention: Common treatment scheme (control group)
Number of subjects: 0
Study: 30170848

Group type: EXPERIMENTAL
Intervention: Biodegradable-polymer sirolimus-eluting stents
Number of subjects: 2119

Group type: COMPARATOR
Intervention: Durable-polymer everolimus-eluting stents
Number of subjects: 2119

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 2119
Study: 26963147

Group type: EXPERIMENTAL
Intervention: Neodymium: yttrium aluminum garnet (Nd:YAG) laser
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Fractional carbon dioxide laser
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control patch
Number of subjects: 32
Study: 24326693

Group type: EXPERIMENTAL
Intervention: Droxidopa (100-600 mg t.i.d.)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 22694796

Group type: EXPERIMENTAL
Intervention: 10-week health promotion intervention targeting physical activity and healthy eating
Number of subjects: 324

Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 324
Study: 20177025

Group type: EXPERIMENTAL
Intervention: Narrow Band Imaging (NBI)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Conventional White Light Imaging (WLI)
Number of subjects: 320
Study: 17974866

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 395

Group type: COMPARATOR
Intervention: No anti-Alzheimer drugs
Number of subjects: 395

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 395
Study: 16280656

Group type: EXPERIMENTAL
Intervention: Zinc gluconate glycine lozenges
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 75
Study: 31549625

Group type: EXPERIMENTAL
Intervention: bococizumab 50, 100, or 150 mg
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: bococizumab
Number of subjects: 218

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 218

Group type: COMPARATOR
Intervention: ezetimibe 10 mg
Number of subjects: 218
Study: 11028483

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate 10 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 8986929

Group type: EXPERIMENTAL
Intervention: Low salt intake (40 mmol/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High salt intake (170 mmol/day)
Number of subjects: 14
Study: 1352328

Group type: EXPERIMENTAL
Intervention: Guarina (guar gum)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 6714903

Group type: EXPERIMENTAL
Intervention: Antacid A (high magnesium content)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Al-Ca-antacid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antacid B (lower magnesium content)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triple-combination (Al, Mg, Ca)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Al-Ca-antacid and Al-Mg-Ca-antacid
Number of subjects: 0
Study: 31490427

Group type: EXPERIMENTAL
Intervention: RST-SS (Repeated-Sprint Training with Straight Sprints)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: RST-COD (Repeated-Sprint Training with Change of Direction)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Between-group analysis
Number of subjects: 20
Study: 31152977

Group type: EXPERIMENTAL
Intervention: Sildenafil 100 mg (single oral dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29855105

Group type: EXPERIMENTAL
Intervention: 112 interactive text messages delivered over 12 weeks
Number of subjects: 825

Group type: COMPARATOR
Intervention: 89 texts on general health (control)
Number of subjects: 825
Study: 27080318

Group type: EXPERIMENTAL
Intervention: Personalised self-management support (discussing SeMaS results and tailored support)
Number of subjects: 644

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 644
Study: 24952281

Group type: EXPERIMENTAL
Intervention: theory-based counseling program led by a community health worker (promotora)
Number of subjects: 600

Group type: COMPARATOR
Intervention: usual care (control arm)
Number of subjects: 600
Study: 22953514

Group type: EXPERIMENTAL
Intervention: Virtual microscopy (VM) instruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional microscopy (TM) instruction
Number of subjects: 0
Study: 21163048

Group type: COMPARATOR
Intervention: Conventional group (n = 39)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fat clearance group (n = 36)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Comparison of N classification
Number of subjects: 75
Study: 18486458

Group type: EXPERIMENTAL
Intervention: Rapid CRP test (NycoCard)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual laboratory technique for CRP
Number of subjects: 227
Study: 16401957

Group type: EXPERIMENTAL
Intervention: Opiate antagonist detoxification under general anesthesia
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 86
Study: 12662246

Group type: EXPERIMENTAL
Intervention: Antenatal group interventions (educational or supportive)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Structured intervention
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Interpersonal therapy
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Unvalidated interventions
Number of subjects: 5
Study: 10651701

Group type: EXPERIMENTAL
Intervention: terbinafine 250 mg daily for 12 weeks
Number of subjects: 137

Group type: COMPARATOR
Intervention: fluconazole 150 mg once weekly for 12 weeks
Number of subjects: 137

Group type: COMPARATOR
Intervention: fluconazole 150 mg once weekly for 24 weeks
Number of subjects: 137
Study: 8885738

Group type: EXPERIMENTAL
Intervention: Supine position after epidural analgesia
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Supine position with fluid bolus
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Supine position after epidural injection
Number of subjects: 21

Group type: COMPARATOR
Intervention: Lateral position after fluid bolus or epidural
Number of subjects: 21
Study: 1519688

Group type: EXPERIMENTAL
Intervention: Orotracheal intubation (group A)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nasotracheal intubation (group B)
Number of subjects: 68
Study: 31810763

Group type: EXPERIMENTAL
Intervention: Simulation-based tutorial
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 30198912

Group type: EXPERIMENTAL
Intervention: Static stretching exercises for ankle evertor and dorsiflexor muscles, performed 5 days a week for 6 weeks.
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no intervention specified).
Number of subjects: 23
Study: 28790547

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg in the morning for 28 days, analgesic (diclofenac 75 mg), high fluid intake
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group received analgesic (diclofenac 75 mg), high fluid intake
Number of subjects: 104
Study: 24347430

Group type: EXPERIMENTAL
Intervention: Accelerated radiotherapy with carbogen breathing and nicotinamide (ARCON)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Accelerated radiotherapy
Number of subjects: 0
Study: 23642125

Group type: EXPERIMENTAL
Intervention: Dexamethasone (12 mg administered in two syringes, 24 hours apart)
Number of subjects: 1449

Group type: COMPARATOR
Intervention: Betamethasone (11.4 mg administered in two syringes, 24 hours apart)
Number of subjects: 1449
Study: 21112155

Group type: EXPERIMENTAL
Intervention: Acamprosate 666 mg three times daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 19623836

Group type: EXPERIMENTAL
Intervention: Single-dose antibiotic prophylaxis (cephalexin, gentamycin, cephazolin)
Number of subjects: 0
Study: 17520382

Group type: EXPERIMENTAL
Intervention: ERAS
Number of subjects: 34
Study: 15122056

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD) with CVD
Number of subjects: 44
Study: 11239843

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass surgery
Number of subjects: 501

Group type: COMPARATOR
Intervention: Coronary angioplasty
Number of subjects: 501
Study: 9846800

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration (GTR) with a bioabsorbable membrane, Resolut
Number of subjects: 9

Group type: COMPARATOR
Intervention: Open debridement procedure (control)
Number of subjects: 9
Study: 7848882

Group type: EXPERIMENTAL
Intervention: CMF-based adjuvant chemotherapy
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: Local-regional treatment alone
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: CMF chemotherapy
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: CMF plus Adriamycin (doxorubicin)
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: CMF-based chemotherapy
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: Age > or = 50 years at surgery
Number of subjects: 2465

Group type: EXPERIMENTAL
Intervention: Age < 50 years at surgery
Number of subjects: 2465
Study: 2908133

Group type: EXPERIMENTAL
Intervention: Ketazolam 15 mg
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 30998750

Group type: EXPERIMENTAL
Intervention: Yunnan Minority children
Number of subjects: 10037

Group type: EXPERIMENTAL
Intervention: Yunnan Han children
Number of subjects: 10037

Group type: COMPARATOR
Intervention: Guangdong Han children
Number of subjects: 10037
Study: 27817180

Group type: EXPERIMENTAL
Intervention: Self-Administered Stress Management Training (SSMT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Usual Care (UCO)
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: SSMT with psychotropic agent
Number of subjects: 219
Study: 25880278

Group type: EXPERIMENTAL
Intervention: Plain cigarette packs
Number of subjects: 128

Group type: COMPARATOR
Intervention: Usual UK brand
Number of subjects: 128
Study: 24348500

Group type: EXPERIMENTAL
Intervention: Psychosocial support intervention consisting of three components over 12 months
Number of subjects: 230

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 230
Study: 21150199

Group type: EXPERIMENTAL
Intervention: Topical methylprednisolone applied to the round window during cochlear implantation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Topical methylprednisolone
Number of subjects: 43
Study: 19730280

Group type: EXPERIMENTAL
Intervention: Clonazepam 4 mg
Number of subjects: 23
Study: 17089357

Group type: EXPERIMENTAL
Intervention: IL-21 + low-dose IL-2
Number of subjects: 5

Group type: COMPARATOR
Intervention: IL-15 + low-dose IL-2
Number of subjects: 5
Study: 15361080

Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 7 days
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Rabeprazole (20 mg b.i.d.), ofloxacin (400 mg b.i.d.), amoxicillin (1000 mg b.i.d.) for 14 days
Number of subjects: 76
Study: 11393446

Group type: EXPERIMENTAL
Intervention: High self-monitors using impression-management tactics (ingratiation, self-promotion, exemplification)
Number of subjects: 339

Group type: COMPARATOR
Intervention: Low self-monitors using impression-management tactics
Number of subjects: 339
Study: 9327336

Group type: EXPERIMENTAL
Intervention: Rectal immunization
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Intramuscular immunization
Number of subjects: 16
Study: 8424302

Group type: EXPERIMENTAL
Intervention: Nifedipine (9 micrograms.kg‐1 x h‐1) during CPB
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (no calcium channel blocker)
Number of subjects: 16
Study: 3316308

Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31217028

Group type: EXPERIMENTAL
Intervention: Quality improvement package (SUSTAIN) including training, mentoring, feedback, and introduction of portable fetal heart monitors (Moyo®) and neonatal heart rate monitors (Neobeat®).
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Quality improvement training and mentoring for health workers on standard basic neonatal resuscitation and essential newborn care.
Number of subjects: 8
Study: 28638025

Group type: EXPERIMENTAL
Intervention: Music therapy exercises on the 3rd, 5th, 7th and 9th days of rehabilitation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Basic set of physical exercises (control group)
Number of subjects: 45